Low- versus standard-dose alteplase in patients on prior antiplatelet therapy: the ENCHANTED trial (enhanced control of hypertension and thrombolysis stroke study)
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
American Heart Association
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
7
item.page.accessRights
item.page.other
item.page.references
Abstract
BACKGROUND AND PURPOSE:
Many patients receiving thrombolysis for acute ischemic stroke are on prior antiplatelet therapy (APT), which may increase symptomatic intracerebral hemorrhage risk. In a presp...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Stroke. 2017 Jul;48(7):1877-1883
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026